Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033924 · ClinicalTrials.gov registry record · NA
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
A NA study of Peripheral Artery Disease, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 3
- Study locations
NCT06033924: Recruiting NA study of Peripheral Artery Disease, sponsored by VA Office of Research and Development.
NCT06033924 is a NA study of Peripheral Artery Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 225 participants, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (84% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033924, a NA study of Peripheral Artery Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 3
- Study locations
Study Summary
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
Primary Outcome
measured using the Gardener-Sinner protocol treadmill test, a validated protocol for measuring maximal and claudication free walking distance among patients with PAD, used in clinical care
Conditions Studied
Interventions
- BEHAVIORAL Walking Program: Internet-based
- BEHAVIORAL Walking Program: Telehealth-based
Study Locations (3)
Alabama
- Birmingham VA Medical Center, Birmingham, AL - Birmingham
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2027-10-29 |
| Phase | NA |
What NCT06033924 shows while recruiting
NCT06033924 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (84% higher).
The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Walking Program: Internet-based is the first listed.
NCT06033924 reports a single indexed study location in Alabama, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06033924 about?
NCT06033924 is a clinical study titled "Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease". Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, ...
What is the current status of trial NCT06033924?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2024-07-01. Estimated completion is 2027-10-29.
What conditions does trial NCT06033924 study?
This clinical trial studies the following conditions: Peripheral Artery Disease.
What interventions are being tested in trial NCT06033924?
The interventions under investigation include: Walking Program: Internet-based (BEHAVIORAL), Walking Program: Telehealth-based (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033924?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033924 being conducted?
This trial has 3 study locations across Alabama, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06033924's enrollment target sits among peer trials
225 10th of 50 higher than 41 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
-
Oxygen-guided Supervised Exercise Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI